Reassessing Rituximab in Membranous Nephropathy: Efficacy, Limitations, and the Path Ahead.

ABSTRACT:

SUBMITTER: Logt AV 

PROVIDER: S-EPMC12446930 | biostudies-literature | 2025 Sep

REPOSITORIES: biostudies-literature